Telomir Pharmaceuticals Inc (TELO)

Finanzdaten der Telomir Pharmaceuticals Inc-Aktie (TELO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	69.46%1.76	1.04	2.13	1.15	5.07
Research and Development	4.94%0.44	0.47	1.30	0.76	0.04
	73.73%-1.72	-0.99	-2.06	-1.10	-5.07
Attributable To Parent	73.73%-1.72	-0.99	-2.06	-1.10	-5.07
Available To Common Stockholders, Basic	-47.84	-	-	-1.10	-5.07
Preferred Stock Dividends And Other Adjustments	46.11	-	-	-	-
Basic Average Shares	76.95%60.84	34.38	-	32.40	30.01
Diluted Average Shares	76.95%60.84	34.38	-	32.40	30.01
Basic Earnings Per Share	2,533%-0.79	-0.03	-	-0.03	0.17
Diluted Earnings Per Share	2,533%-0.79	-0.03	-	-0.03	0.17